Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled …
C Klipping, I Duijkers, MP Fortier, J Marr… - Journal of Family …, 2012 - srh.bmj.com
Background The contraceptive efficacy and tolerability of a new flexible extended regimen of
ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg to extend the menstrual cycle and …
ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg to extend the menstrual cycle and …
Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label …
T Strowitzki, B Kirsch, J Elliesen - Journal of Family Planning and …, 2012 - srh.bmj.com
Objectives The aim of this Phase III, multicentre, open-label, randomised study was to
compare the efficacy and safety of ethinylestradiol (EE)/drospirenone (DRSP) in a new …
compare the efficacy and safety of ethinylestradiol (EE)/drospirenone (DRSP) in a new …
Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study
JT Jensen, SG Garie, D Trummer, J Elliesen - Contraception, 2012 - Elsevier
BACKGROUND: Unscheduled bleeding may affect satisfaction and compliance with
extended oral contraceptive (OC) regimens. The bleeding patterns of two variants of a …
extended oral contraceptive (OC) regimens. The bleeding patterns of two variants of a …
10th Summit Meeting consensus: recommendations for regulatory approval for hormonal male contraception
P Aaltonen, JK Amory, RA Anderson… - Journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
10th Summit Meeting consensus: recommendations for regulatory approval for hormonal
male contraception 10th Summit Meeting consensus: recommendations for regulatory …
male contraception 10th Summit Meeting consensus: recommendations for regulatory …
Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study
C Klipping, I Duijkers, MP Fortier, J Marr… - Journal of Family …, 2012 - srh.bmj.com
Background This study was designed to assess the long-term safety and tolerability of a new
flexible extended regimen of ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg, which …
flexible extended regimen of ethinylestradiol (EE) 20 μg/drospirenone (DRSP) 3 mg, which …
Adherence with ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic …
I Wiegratz, J Elliesen, AM Paoletti… - International journal of …, 2015 - Taylor & Francis
Objective To evaluate the effect of a digital dispenser's acoustic alarm function on
adherence to ethinylestradiol (EE) 20 μg/drospirenone 3 mg in a flexible extended regimen …
adherence to ethinylestradiol (EE) 20 μg/drospirenone 3 mg in a flexible extended regimen …
Adherence to a flexible extended regimen for oral hormonal contraception provided in blister packaging compared with an adherence-supporting digital tablet …
J Elliesen, D Trummer - International journal of women's health, 2016 - Taylor & Francis
Background The Clyk™ digital pill dispenser helps ensure correct and consistent
administration of a flexible extended regimen of the combined oral contraceptive …
administration of a flexible extended regimen of the combined oral contraceptive …
[CITATION][C] Untersuchungen zur Wirksamkeit von Dehydroepiandrosteron in Kombination mit Östradiol zur Substitutionsbehandlung von klimakterischen …
J Elliesen - 1993 - Uitgever niet vastgesteld